Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Nordgaard-Lassen

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|December 19, 2008
[Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab)]Synne Semb, Inge Nordgaard-Lassen
Inflammatory Bowel Diseases|November 15, 2014
Incorrect citation and analysis in meta-analysisSigne Wildt, Jüri Johannes Rumessen, Inge Nordgaard-Lassen
European Journal of Gastroenterology & Hepatology|January 29, 2019
Challenges and obstacles in the transition process through the eyes of the gastroenterologistMette Hald, Katrine Carlsen, Inge Nordgaard-Lassen, et al.
European Journal of Gastroenterology & Hepatology|June 9, 2007
Metabolic and inflammatory faecal markers in collagenous colitisSigne Wildt, Inge Nordgaard-Lassen, Flemming Bendtsen, et al.
Scandinavian Journal of Gastroenterology|February 6, 2014
The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatmentKlaus Theede, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen, et al.
Journal of Crohn'S & Colitis|May 10, 2015
The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis PatientsKlaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Ugeskrift for Laeger|October 9, 2014
[Faecal calprotectin is a useful biomarker for intestinal inflammation]Klaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Therapeutic Advances in Gastroenterology|December 25, 2010
Possible interactions between dietary fibres and 5-aminosalicylic acid [corrected]Camilla Henriksen, Steen Hansen, Inge Nordgaard-Lassen, et al.
Nutrition Research (New York, N.Y.)|October 27, 2009
A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized populationUlrich Christian Bang, Synne Semb, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|February 12, 2019
Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trialMie Dilling Kjær, Niels Qvist, Inge Nordgaard-Lassen, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|December 19, 2008
[Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab)]Synne Semb, Inge Nordgaard-Lassen
Inflammatory Bowel Diseases|November 15, 2014
Incorrect citation and analysis in meta-analysisSigne Wildt, Jüri Johannes Rumessen, Inge Nordgaard-Lassen
European Journal of Gastroenterology & Hepatology|January 29, 2019
Challenges and obstacles in the transition process through the eyes of the gastroenterologistMette Hald, Katrine Carlsen, Inge Nordgaard-Lassen, et al.
European Journal of Gastroenterology & Hepatology|June 9, 2007
Metabolic and inflammatory faecal markers in collagenous colitisSigne Wildt, Inge Nordgaard-Lassen, Flemming Bendtsen, et al.
Scandinavian Journal of Gastroenterology|February 6, 2014
The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatmentKlaus Theede, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen, et al.
Journal of Crohn'S & Colitis|May 10, 2015
The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis PatientsKlaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Ugeskrift for Laeger|October 9, 2014
[Faecal calprotectin is a useful biomarker for intestinal inflammation]Klaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen, et al.
Therapeutic Advances in Gastroenterology|December 25, 2010
Possible interactions between dietary fibres and 5-aminosalicylic acid [corrected]Camilla Henriksen, Steen Hansen, Inge Nordgaard-Lassen, et al.
Nutrition Research (New York, N.Y.)|October 27, 2009
A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized populationUlrich Christian Bang, Synne Semb, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|February 12, 2019
Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trialMie Dilling Kjær, Niels Qvist, Inge Nordgaard-Lassen, et al.
Pageof 3